AlTi Global Inc. Purchases Shares of 18,840 Encompass Health Corporation $EHC

Key Points

• AlTi Global Inc. acquired 18,840 shares of Encompass Health Corporation, worth approximately $1.9 million, in the first quarter.
• Encompass Health recently reported a 12.0% year-over-year revenue increase for the quarter, with earnings per share surpassing analysts' estimates.
• The company announced an increase in its quarterly dividend to $0.19 per share, up from $0.17, with a record date set for October 1st.

AlTi Global Inc. purchased a new stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The firm purchased 18,840 shares of the company's stock, valued at approximately $1,908,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Nuveen LLC bought a new stake in shares of Encompass Health during the 1st quarter worth $50,665,000. Farallon Capital Management LLC boosted its stake in shares of Encompass Health by 15,266.7% during the 4th quarter. Farallon Capital Management LLC now owns 461,000 shares of the company's stock worth $42,573,000 after acquiring an additional 458,000 shares in the last quarter. T. Rowe Price Investment Management Inc. boosted its stake in shares of Encompass Health by 25.6% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company's stock worth $210,756,000 after acquiring an additional 424,691 shares in the last quarter. American Century Companies Inc. boosted its stake in shares of Encompass Health by 78.6% during the 1st quarter. American Century Companies Inc. now owns 723,169 shares of the company's stock worth $73,243,000 after acquiring an additional 318,251 shares in the last quarter. Finally, Invesco Ltd. boosted its stake in shares of Encompass Health by 5.1% during the 1st quarter. Invesco Ltd. now owns 5,818,783 shares of the company's stock worth $589,326,000 after acquiring an additional 282,532 shares in the last quarter. 97.25% of the stock is owned by institutional investors.

Encompass Health Price Performance

EHC opened at $123.44 on Thursday. The stock has a fifty day moving average of $116.80 and a 200-day moving average of $111.54. The firm has a market capitalization of $12.43 billion, a P/E ratio of 24.16, a PEG ratio of 2.13 and a beta of 0.92. Encompass Health Corporation has a 12-month low of $87.85 and a 12-month high of $124.67. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.20 by $0.20. The company had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The company's revenue for the quarter was up 12.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.11 earnings per share. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Equities analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a dividend of $0.19 per share. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Wednesday, October 1st. Encompass Health's dividend payout ratio is 14.87%.

Insider Activity

In related news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president directly owned 18,846 shares in the company, valued at approximately $2,329,177.14. This trade represents a 5.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.00% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Wall Street Zen lowered Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. KeyCorp raised their price objective on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 27th. UBS Group raised their price objective on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective for the company in a research note on Thursday, June 5th. Finally, Truist Financial increased their target price on Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a report on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the stock. According to data from MarketBeat.com, Encompass Health currently has a consensus rating of "Buy" and an average price target of $134.00.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.